Cysteine cathepsin proteases as pharmacological targets in cancer
Top Cited Papers
- 1 January 2008
- journal article
- review article
- Published by Elsevier BV in Trends in Pharmacological Sciences
- Vol. 29 (1), 22-28
- https://doi.org/10.1016/j.tips.2007.10.011
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painProceedings of the National Academy of Sciences of the United States of America, 2007
- Schistosomiasis Mansoni: Novel Chemotherapy Using a Cysteine Protease InhibitorPLoS Medicine, 2007
- An Orally Active Cathepsin K Inhibitor, Furan-2-Carboxylic Acid, 1-{1-[4-Fluoro-2-(2-oxo-pyrrolidin-1-yl)-phenyl]-3-oxo-piperidin-4-ylcarbamoyl}-cyclohexyl)-amide (OST-4077), Inhibits Osteoclast Activity in Vitro and Bone Loss in Ovariectomized RatsJournal of Pharmacology and Experimental Therapeutics, 2006
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- Overexpression of Stefin A in Human Esophageal Squamous Cell Carcinoma Cells Inhibits Tumor Cell Growth, Angiogenesis, Invasion, and MetastasisClinical Cancer Research, 2005
- Multiple Roles for Cysteine Cathepsins in CancerCell Cycle, 2004
- Cysteine cathepsins in human cancerBiological Chemistry, 2004
- Crystal Structures of Calpain–E64 and –Leupeptin Inhibitor Complexes Reveal Mobile Loops Gating the Active SiteJournal of Molecular Biology, 2004
- Modulation of cystatin C expression impairs the invasive and tumorigenic potential of human glioblastoma cellsOncogene, 2002
- Novel epoxysuccinyl peptides A selective inhibitor of cathepsin B, in vivoFEBS Letters, 1991